Veterinary Medicines Information website

Pimocard 2.5 mg Flavoured Tablets for Dogs

Authorised
  • Pimobendan

Product identification

Medicine name:
Pimocard 2.5 mg Flavoured Tablets for Dogs
Active substance:
  • Pimobendan
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Pimobendan
    2.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC01CE90
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:
  • 10 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
  • 10 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.
  • 2 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.
  • 25 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
  • 25 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.
  • 5 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
  • 2 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
  • 5 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Eurovet Animal Health B.V.
  • Genera d.d.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/020/MR/16-S
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0283/002
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023